Healthcare provider profile · identity verified

Nick Buttar, M.D.

Family Practice · BURTON, MI · NPI 1326085861

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	384	37
Atorvastatin Calcium	Atorvastatin Calcium	368	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	313	39
Levothyroxine Sodium	Levothyroxine Sodium	286	48
Metoprolol Tartrate	Metoprolol Tartrate	253	36
Furosemide	Furosemide	247	46
Potassium Chloride	Potassium Chloride	231	40
Alprazolam	Alprazolam	205	25
Lorazepam	Lorazepam	185	39
Omeprazole	Omeprazole	183	38
Amlodipine Besylate	Amlodipine Besylate	167	34
Donepezil Hcl	Donepezil Hcl	167	20
Tamsulosin Hcl	Tamsulosin Hcl	164	29
Lisinopril	Lisinopril	162	35
Sertraline Hcl	Sertraline Hcl	125	16
Memantine Hcl	Memantine Hcl	123	16
Metformin Hcl	Metformin Hcl	108	16
Xarelto	Rivaroxaban	104	suppressed
Famotidine	Famotidine	103	24
Escitalopram Oxalate	Escitalopram Oxalate	101	19
Gabapentin	Gabapentin	97	23
Prednisone	Prednisone	95	60
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	12
Tramadol Hcl	Tramadol Hcl	90	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	89	suppressed
Levetiracetam	Levetiracetam	89	12
Quetiapine Fumarate	Quetiapine Fumarate	89	22
Losartan Potassium	Losartan Potassium	87	20
Carvedilol	Carvedilol	86	15
Clonazepam	Clonazepam	86	11
Metoprolol Succinate	Metoprolol Succinate	86	22
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	76	21
Pantoprazole Sodium	Pantoprazole Sodium	76	14
Clopidogrel	Clopidogrel Bisulfate	75	12
Pregabalin	Pregabalin	74	suppressed
Allopurinol	Allopurinol	70	19
Hydrochlorothiazide	Hydrochlorothiazide	66	suppressed
Bumetanide	Bumetanide	65	12
Simvastatin	Simvastatin	64	11
Trazodone Hcl	Trazodone Hcl	64	12
Ssd	Silver Sulfadiazine	61	12
Januvia	Sitagliptin Phosphate	59	suppressed
Divalproex Sodium	Divalproex Sodium	58	suppressed
Ondansetron Hcl	Ondansetron Hcl	58	28
Doxycycline Hyclate	Doxycycline Hyclate	56	29
Baclofen	Baclofen	55	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	11
Fluoxetine Hcl	Fluoxetine Hcl	54	suppressed
Meloxicam	Meloxicam	54	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	52	12
Lamotrigine	Lamotrigine	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	12
Hydralazine Hcl	Hydralazine Hcl	48	11
Latanoprost	Latanoprost	48	suppressed
Nifedipine Er	Nifedipine	48	suppressed
Atenolol	Atenolol	47	suppressed
Aripiprazole	Aripiprazole	44	suppressed
Jardiance	Empagliflozin	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Entresto	Sacubitril/Valsartan	42	suppressed
Nystatin	Nystatin	42	25
Albuterol Sulfate	Albuterol Sulfate	41	16
Farxiga	Dapagliflozin Propanediol	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Midodrine Hcl	Midodrine Hcl	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Azithromycin	Azithromycin	37	29
Bethanechol Chloride	Bethanechol Chloride	37	suppressed
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	37	suppressed
Clobazam	Clobazam	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Lidocaine	Lidocaine	34	suppressed
Olanzapine	Olanzapine	31	suppressed
Risperidone	Risperidone	31	suppressed
Brilinta	Ticagrelor	30	suppressed
Carbamazepine	Carbamazepine	30	suppressed
Paliperidone Er	Paliperidone	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	17
Metformin Hcl Er	Metformin Hcl	29	suppressed
Torsemide	Torsemide	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	19
Finasteride	Finasteride	28	suppressed
Lagevrio (Eua)	Molnupiravir	28	27
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Rytary	Carbidopa/Levodopa	27	suppressed
Fentanyl	Fentanyl	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Budesonide	Budesonide	25	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	25	25
Alendronate Sodium	Alendronate Sodium	24	suppressed
Cephalexin	Cephalexin	24	18
Methylphenidate Er	Methylphenidate Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Primidone	Primidone	23	suppressed
Klor-Con 8	Potassium Chloride	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	suppressed
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	20	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	16
Oxcarbazepine	Oxcarbazepine	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Apidra Solostar	Insulin Glulisine	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Phenytoin	Phenytoin	17	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	11
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Lactulose	Lactulose	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Topiramate	Topiramate	15	suppressed
Valsartan	Valsartan	15	suppressed
Alphagan P	Brimonidine Tartrate	14	suppressed
Enulose	Lactulose	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Metolazone	Metolazone	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Austedo Xr	Deutetrabenazine	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Norethindrone Acetate	Norethindrone Acetate	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error